{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/contraception-ius-iud/management/copper-intrauterine-device/","result":{"pageContext":{"chapter":{"id":"52ed621a-9a40-532d-ac51-ba401911db84","slug":"copper-intrauterine-device","fullItemName":"Scenario: Copper intrauterine device","depth":2,"htmlHeader":"<!-- begin field df8e2d48-b8c6-446c-84c8-bca61ff9208f --><h2>Scenario: Copper intrauterine device</h2><!-- end field df8e2d48-b8c6-446c-84c8-bca61ff9208f -->","summary":"Covers the use of the copper intrauterine device (Cu-IUD), including when to start using the IUD; management of common problems (such as lost threads and unscheduled bleeding); management of uncommon problems (such as pregnancy whilst using the device and pelvic inflammatory disease); the advantages, disadvantages, risks, and efficacy of the Cu-IUD; and the subsequent monitoring and follow up required.","htmlStringContent":"<!-- begin item 2fe46b0f-da3e-4ddb-80fa-c1b1e5bce50d --><!-- begin field 9f1f5528-1903-48d3-8c9e-acd900ab9c52 --><p>From age 13 years to 60 years (Female).</p><!-- end field 9f1f5528-1903-48d3-8c9e-acd900ab9c52 --><!-- end item 2fe46b0f-da3e-4ddb-80fa-c1b1e5bce50d -->","topic":{"id":"5fd4f695-2824-524f-97fd-1ffbc1ed1ad6","topicId":"14c8f64d-295a-4e1a-92b1-5280c3cce30f","topicName":"Contraception - IUS/IUD","slug":"contraception-ius-iud","lastRevised":"Last revised in February 2021","chapters":[{"id":"fa63ff86-38d1-5d04-b121-e6ba3a5b60d3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a6a86d04-8f24-5c92-b340-fe91a3323c4f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"841f70dc-d28e-5fb0-a68a-d6dac27e0ffb","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5c7dee41-86ab-5d74-b647-984a7323f97c","slug":"changes","fullItemName":"Changes"},{"id":"24837e86-76a3-581e-ae6a-b827bf3bd948","slug":"update","fullItemName":"Update"}]},{"id":"abaf741b-ff01-59e1-8db9-510b749e87b7","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"b6f49269-86ef-5810-8059-10d065f377f0","slug":"goals","fullItemName":"Goals"},{"id":"a95a933e-1a31-5be4-9009-21b8a79da2ae","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"defba0ce-4495-5c71-8bfb-d04ee36d79e9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f24f3c36-9720-5dd2-a7c5-8552fd694e1c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ff8474b0-1358-5b27-8928-58d81c1aeb7a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - options for local implementation"},{"id":"f10c46df-f19e-51c2-bd07-c680f266f212","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7a441ab2-b820-5821-8c27-5a2e71c741aa","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c7698130-9973-5145-aa0e-981a48972d36","slug":"definition","fullItemName":"Definition"},{"id":"9dbc8287-ded7-50ad-a43e-d87edeebb462","slug":"types","fullItemName":"Types"},{"id":"35c8bc48-3518-55a7-ae5a-a86db3ff3a56","slug":"mode-of-action","fullItemName":"Mode of action"},{"id":"aab10d36-adb8-52f6-895c-f7ce73e2ef4c","slug":"efficacy","fullItemName":"Efficacy"},{"id":"91843ac0-bc35-5798-b0e9-da4d52b30a69","slug":"advantages-disadvantages","fullItemName":"Advantages and disadvantages"},{"id":"6058a967-a6d7-52cd-9cf5-d2d480ec4d7d","slug":"where-to-obtain","fullItemName":"Where to obtain"}]},{"id":"98bf4d7c-c4c4-5c19-9821-a8c43bb9b0fe","fullItemName":"Management","slug":"management","subChapters":[{"id":"3aef47bd-6fd3-5fc1-a254-61098a484a64","slug":"levonorgestrel-intrauterine-system","fullItemName":"Scenario: Levonorgestrel intrauterine system"},{"id":"52ed621a-9a40-532d-ac51-ba401911db84","slug":"copper-intrauterine-device","fullItemName":"Scenario: Copper intrauterine device"}]},{"id":"08730ed3-ce27-5f45-b6fa-9747b4d35a64","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"cfebd8c6-03b3-541a-8425-4f73a4eafe81","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"23a8e2fd-3eac-5088-919c-f81757e13399","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0f38e730-f213-59fe-afba-bf3f2f2b92e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"64158eb2-3052-5f75-872c-1f839e443457","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"a8fc3514-5b7d-55bb-a8d1-c58fb846dde6","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"71aff73b-554d-5df3-b36c-cc7490291d7f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"fb77b532-9628-57cb-a96d-9533a61e730c","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"98bf4d7c-c4c4-5c19-9821-a8c43bb9b0fe","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"8c83d25f-1418-5674-97c2-006b205f48cb","slug":"initial-assessment","fullItemName":"Initial assessment","depth":3,"htmlHeader":"<!-- begin field b2fee003-a448-4f9b-a40b-acce0143d77d --><h3>How should I assess a woman considering using a copper intrauterine device?</h3><!-- end field b2fee003-a448-4f9b-a40b-acce0143d77d -->","summary":null,"htmlStringContent":"<!-- begin item 24f6174e-d0a6-4843-ac33-5cff0a061510 --><!-- begin field 6f337e85-05d9-46b9-9506-acce0143d77d --><p><strong>Healthcare professionals offering intrauterine contraception (IUC) should hold the appropriate letter of competence in intrauterine techniques from the Faculty of Sexual and Reproductive Healthcare (FSRH), or an equivalent.</strong></p><ul><li><strong><strong>If the copper intrauterine device (Cu-IUD) is being considered:</strong></strong><br><ul><li>Carry out a full medical and sexual history to assess the woman's suitability for use of the method and the woman's risk of sexually transmitted infections (STIs).<ul><li>Check the <a href=\"https://www.fsrh.org/standards-and-guidance/documents/ukmec-2016/\" data-hyperlink-id=\"4c213498-0fcf-4a53-95d1-acd200badc06\">UK Medical Eligibility Criteria for Contraceptive Use</a> (UKMEC) to assess the woman’s eligibility. </li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a> for detailed information on assessing a woman considering a Cu-IUD.</li></ul></li><li>In women with heavy menstrual bleeding, consider the need for additional investigations, such as full blood count, pelvic ultrasound scan, and endometrial biopsy, prior to or at the same time as Cu-IUD insertion, particularly if other treatments for heavy menstrual bleeding have not been effective or if a woman has risk factors for gynaecological disease.</li><li>If a woman attends to discuss IUC in advance of the procedure, pelvic examination is not required unless indicated by the clinical history.</li></ul></li><li><strong>At the time of insertion:</strong><ul><li>Perform a bimanual pelvic examination before inserting the IUC.</li><li>Obtain valid consent from the woman before pelvic examination and IUC insertion.</li></ul></li></ul><!-- end field 6f337e85-05d9-46b9-9506-acce0143d77d --><!-- end item 24f6174e-d0a6-4843-ac33-5cff0a061510 -->","subChapters":[{"id":"92b43c99-656b-54b8-af0f-c470b3cd6759","slug":"basis-for-recommendation-6c1","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 35d3b340-113e-43b6-80af-acce0143d77d --><h4>Basis for recommendation</h4><!-- end field 35d3b340-113e-43b6-80af-acce0143d77d -->","summary":null,"htmlStringContent":"<!-- begin item 6c11853e-0abe-44a2-89f6-80289ab49da7 --><!-- begin field 5a91fbe8-856f-4111-a65b-acce0143d77d --><p>These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guideline <em>Intrauterine contraception (April 2015, amended September 2019)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>].</p><!-- end field 5a91fbe8-856f-4111-a65b-acce0143d77d --><!-- end item 6c11853e-0abe-44a2-89f6-80289ab49da7 -->","subChapters":[]}]},{"id":"658e7b33-56a1-5eb3-8731-d0d8ca6fa3ab","slug":"starting-or-switching-to-a-cu-iud","fullItemName":"Starting or switching to a Cu-IUD","depth":3,"htmlHeader":"<!-- begin field 0f037d24-1d9d-43ff-af1d-acce014fef69 --><h3>How should I start (or switch to) a copper intrauterine device?</h3><!-- end field 0f037d24-1d9d-43ff-af1d-acce014fef69 -->","summary":null,"htmlStringContent":"<!-- begin item 65df091c-a962-4175-b6e4-e4c2f46cb562 --><!-- begin field bda6741d-491f-47e6-82d3-acce014fef69 --><!-- end field bda6741d-491f-47e6-82d3-acce014fef69 --><!-- end item 65df091c-a962-4175-b6e4-e4c2f46cb562 -->","subChapters":[{"id":"a159910a-6639-5712-bf89-99f4f0527ab1","slug":"starting-a-cu-iud","fullItemName":"Starting a Cu-IUD","depth":4,"htmlHeader":"<!-- begin field 2a9e9abb-c9c3-4215-a37a-accf00eb38fb --><h4>How should I start a copper intrauterine device?</h4><!-- end field 2a9e9abb-c9c3-4215-a37a-accf00eb38fb -->","summary":null,"htmlStringContent":"<!-- begin item dae92309-c745-4610-a6df-da5e3e42240f --><!-- begin field 1868040a-65be-4f3d-8fd0-accf00eb38fc --><p><strong>Healthcare professionals offering intrauterine contraception (IUC) should hold the appropriate letter of competence in intrauterine techniques from the Faculty of Sexual and Reproductive Healthcare (FSRH), or an equivalent.</strong></p><ul><li><strong>In most circumstances, including in women using the <strong>copper intrauterine device (Cu-IUD) for the first time</strong>:</strong><ul><li>Insert the Cu-IUD at any time in the menstrual cycle if it is <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/management/copper-intrauterine-device/#excluding-pregnancy\">reasonably certain that the woman is not pregnant</a> or at risk of pregnancy (unless it qualifies for use as emergency contraception [EC]). A Cu-IUD is effective immediately so no additional contraception is required.</li><li>If unprotected sexual intercourse (UPSI) occurred before insertion and there is a risk of pregnancy, a Cu-IUD can safely be inserted up to 5 days (120 hours) after the first episode of UPSI or within 5 days of the earliest expected time of ovulation (for example, on day 19 of a regular, 28-day cycle), whichever is later.</li></ul></li><li><strong>If <strong>the woman is </strong>starting a Cu-IUD in the postpartum period (including post caesarean section and breastfeeding):</strong><ul><li>Insert the Cu-IUD within 48 hours of delivery, or from 4 weeks after delivery if it is <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/management/copper-intrauterine-device/#excluding-pregnancy\">reasonably certain that the woman is not pregnant</a> or at risk of pregnancy (unless it qualifies for use as EC).</li><li>Additional contraceptive precautions are not required.</li></ul></li><li><strong><strong>If <strong>the woman is </strong>starting a Cu-IUD after an</strong> abortion (all induced or spontaneous abortions less than 24 weeks’ gestation):</strong><br><ul><li>Post surgical abortion, insert the Cu-IUD at the end of the procedure.</li><li>Post medical abortion, insert the Cu-IUD any time after completion of the second part of the abortion (that is, passage of products of conception confirmed by clinical assessment and/or local protocols).</li><li>Additional contraceptive precautions are not required.</li></ul></li><li><strong><strong>If <strong>the woman is </strong>starting a Cu-IUD after</strong> oral EC:</strong><ul><li>Insert the Cu-IUD within the first 5 days (120 hours) after the first episode of UPSI or within 5 days of the earliest expected time of ovulation (for example, on day 19 of a regular, 28-day cycle), whichever is later. No additional precaution is required.</li><li>Outside of the above criteria, do not insert the Cu-IUD until pregnancy can be excluded with a pregnancy test performed no sooner than 3 weeks after the last episode of UPSI.</li></ul></li></ul><!-- end field 1868040a-65be-4f3d-8fd0-accf00eb38fc --><!-- end item dae92309-c745-4610-a6df-da5e3e42240f -->","subChapters":[]},{"id":"71df6deb-fa85-5708-bfbd-f151bc04824c","slug":"switching-to-a-cu-iud","fullItemName":"Switching to a Cu-IUD","depth":4,"htmlHeader":"<!-- begin field 180b1134-f65a-49ec-af28-accf00eb38fc --><h4>How should I switch to the copper intrauterine device from other methods of contraception?</h4><!-- end field 180b1134-f65a-49ec-af28-accf00eb38fc -->","summary":null,"htmlStringContent":"<!-- begin item 26ad9091-32f7-4cf9-97d7-3727dd1da7a0 --><!-- begin field ea4ba03b-0d82-4125-85e2-accf00eb38fc --><p><strong>Healthcare professionals offering intrauterine contraception (IUC) should hold the appropriate letter of competence in intrauterine techniques from the Faculty of Sexual and Reproductive Healthcare (FSRH), or an equivalent.</strong></p><ul><li><strong>If the woman is switching from another method of contraception to the copper intrauterine device (Cu-IUD):</strong><br><ul><li>Insert the Cu-IUD at any time in the menstrual cycle provided that the other method of contraception has been used consistently and correctly and it is <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/management/copper-intrauterine-device/#excluding-pregnancy\">reasonably certain that the woman is not pregnant</a> or at risk of pregnancy (except in those circumstances that would qualify for use as emergency contraception). No additional precautions are required.</li><li><strong>If the woman is switching from the levonorgestrel intrauterine system (LNG-IUS) to the Cu-IUD, </strong>advise her to abstain from sexual intercourse or use a barrier method of contraception (such as condoms) for 7 days before replacement in case the Cu-IUD cannot be inserted.</li></ul></li><li><strong>If an existing Cu-IUD is being replaced with a new Cu-IUD:</strong><ul><li>Replace the existing Cu-IUD with the new Cu-IUD at any time in the cycle. No additional contraception is required if the new Cu-IUD is inserted immediately after removing the existing Cu-IUD.</li><li>Ideally, advise the woman to abstain from sexual intercourse or use a barrier method of contraception (such as condoms) or for 7 days before the replacement in case the Cu-IUD cannot be inserted. </li></ul></li></ul><!-- end field ea4ba03b-0d82-4125-85e2-accf00eb38fc --><!-- end item 26ad9091-32f7-4cf9-97d7-3727dd1da7a0 -->","subChapters":[]},{"id":"2292b2c0-a240-5f2a-a488-694def92e01a","slug":"excluding-pregnancy","fullItemName":"Excluding pregnancy","depth":4,"htmlHeader":"<!-- begin field 1f51a863-04a5-41fb-a676-acce014fef69 --><h4>How can I exclude pregnancy in a woman considering using a copper intrauterine device?</h4><!-- end field 1f51a863-04a5-41fb-a676-acce014fef69 -->","summary":null,"htmlStringContent":"<!-- begin item 72abe0ed-198b-4fb0-bd27-059b4564170b --><!-- begin field f7689fc6-a93a-4ec4-bc58-acce014fef69 --><ul><li><strong>Health professionals can be ‘reasonably certain’ that a woman is not currently pregnant if any one or more of the following criteria are met and there are no symptoms or signs of pregnancy:</strong><ul><li>She has not had intercourse since last normal menses.</li><li>She has been correctly and consistently using a reliable method of contraception.</li><li>She is within the first 7 days of the onset of a normal menstrual period.</li><li>She is not breastfeeding and less than 4 weeks from giving birth.</li><li>She is fully or nearly fully breastfeeding, amenorrhoeic, and less than 6 months postpartum.</li><li>She is within the first 7 days post-termination or miscarriage.</li><li>A pregnancy test is performed no sooner than 3 weeks since the last episode of unprotected sexual intercourse (UPSI) and is negative.</li></ul></li><li><strong>In addition to the conditions mentioned above,</strong> also consider whether a woman is at risk of becoming pregnant as a result of UPSI within the last 7 days.</li></ul><!-- end field f7689fc6-a93a-4ec4-bc58-acce014fef69 --><!-- end item 72abe0ed-198b-4fb0-bd27-059b4564170b -->","subChapters":[]},{"id":"5483951a-3914-594c-b3e9-cf6ee096501f","slug":"basis-for-recommendation-5fb","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 80720f8e-0595-4d28-9112-acce014fef69 --><h4>Basis for recommendation</h4><!-- end field 80720f8e-0595-4d28-9112-acce014fef69 -->","summary":null,"htmlStringContent":"<!-- begin item 5fb94874-c89f-4b93-8c36-de312137fa62 --><!-- begin field 60767bee-f5fc-4aea-a397-acce014fef69 --><p>These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guideline <em>Intrauterine contraception (April 2015, amended September 2019) </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>].</p><h5>When to insert a copper intrauterine device (Cu-IUD)</h5><ul><li>This information is based on the FSRH guidelines on <em>Intrauterine contraception</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>] and <em>Emergency contraception</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2020</a>].<ul><li>The Cu-IUD can be inserted within 5 days (120 hours) after the first unprotected sexual intercourse (UPSI) in a cycle [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2020</a>].</li><li>The earliest implantation is believed to occur 6 days after ovulation (and over 80% of implantations occur 8–10 days after ovulation). Therefore, a Cu-IUD can also be inserted up to 5 days after ovulation (for example, until day 19 of a regular, 28-day cycle) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2020</a>].<ul><li>Ovulation occurs about 14 days before the onset of menstruation.</li><li>It is established practice that the earliest likely ovulation date is estimated as the date of the start of the last menstrual period (LMP) plus the number of days in the shortest cycle minus 14.</li><li>The LMP must be accurately known and cycles must be regular in order to make the estimation [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2020</a>].</li></ul></li></ul></li></ul><!-- end field 60767bee-f5fc-4aea-a397-acce014fef69 --><!-- end item 5fb94874-c89f-4b93-8c36-de312137fa62 -->","subChapters":[]}]},{"id":"32af854e-c402-527c-8645-6269ffe8d901","slug":"risks-adverse-effects","fullItemName":"Risks and adverse effects","depth":3,"htmlHeader":"<!-- begin field 1d472d8f-eabf-49c8-b63e-bca4c42dd52b --><h3>What are the possible risks and adverse effects of the copper intrauterine device?</h3><!-- end field 1d472d8f-eabf-49c8-b63e-bca4c42dd52b -->","summary":null,"htmlStringContent":"<!-- begin item e934caa7-8cc5-4e7e-80f8-367696cf03a4 --><!-- begin field 58b81ac6-a279-4b7e-9a99-08d6152dcfd5 --><ul><li><strong>Possible risks and adverse effects of a copper intrauterine device (Cu-IUD) include:</strong><ul><li style=\"box-sizing: inherit;\"><strong>Pain on insertion</strong> — this may cause discomfort for a few hours but can be relieved with analgesics. </li><li style=\"box-sizing: inherit;\"><strong>Pelvic pain</strong> — pelvic pain or cramping has been reported by some women. </li><li style=\"box-sizing: inherit;\"><strong>Perforation of the wall of the uterus</strong> — this is rare (occurs in less than 2 in 1000 women) and is dependent on the skills of the clinician. There is an increased relative risk of perforation at the time of insertion of intrauterine contraception (IUC) in the postpartum period (within 36 weeks after giving birth) and during breastfeeding; however, the absolute risk of perforation remains low.</li><li style=\"box-sizing: inherit;\"><strong>Expulsion </strong>— the risk of expulsion is around 1 in 20 and is more common in the first year of use, especially within the first 3 months of insertion. There is a small increased risk of expulsion if the device is inserted immediately following surgical or medical termination of pregnancy.</li><li><strong>Pelvic inflammatory disease (PID) </strong>— there is a low risk of PID (1.6 per 1000 women-years), which is strongly related to the insertion procedure and background risk of sexually transmitted infections (STIs). The risk of pelvic infection is greatest in the first few weeks following IUC insertion.</li><li style=\"box-sizing: inherit;\"><strong>Ectopic pregnancy</strong> — the overall risk of ectopic pregnancy when using an IUC is very low, at about 1 in 1000 at 5 years. If pregnancy does occur with an intrauterine method in situ, the risk of an ectopic pregnancy occurring is increased; in some studies, half of the pregnancies that occurred were ectopic. The overall risk of ectopic pregnancy is reduced with the use of IUC when compared with using no contraception because IUCs are very effective methods of contraception overall.</li><li style=\"box-sizing: inherit;\"><strong>Unscheduled bleeding </strong>— irregular, prolonged, or frequent bleeding may occur in the 3–6 months following Cu-IUD insertion, but menstrual bleeding patterns tend to improve with time. </li><li style=\"box-sizing: inherit;\"><strong>Weight gain </strong>— this has been observed with the use of IUC, but evidence to support a causal association is lacking. </li><li style=\"box-sizing: inherit;\"><strong>Decreased libido</strong> — although existing evidence fails to support a negative effect on libido associated with IUC use. </li></ul></li></ul><!-- end field 58b81ac6-a279-4b7e-9a99-08d6152dcfd5 --><!-- end item e934caa7-8cc5-4e7e-80f8-367696cf03a4 -->","subChapters":[{"id":"62b26afd-3676-5ff7-8ba0-521a9e15f97c","slug":"basis-for-recommendation-b23","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2b160b51-70b5-474a-a170-d6bffef6b10b --><h4>Basis for recommendation</h4><!-- end field 2b160b51-70b5-474a-a170-d6bffef6b10b -->","summary":null,"htmlStringContent":"<!-- begin item b23e7f3d-d197-4f73-ae63-896ffcaab7ec --><!-- begin field 05ef1a22-c0fa-4523-aad1-7328f591e30f --><p>These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guideline <em>Intrauterine contraception (April 2015, amended September 2019)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>] and the Medicines and Healthcare products Regulatory Agency (MHRA) drug safety update <em>Intrauterine contraception: uterine perforation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">MHRA, 2015</a>].</p><h5>Weight gain</h5><ul><li>Expert opinion in the FSRH guideline is that weight gain has been observed with the use of intrauterine contraception (IUC), but evidence to support a causal association is lacking. The FSRH concluded that it is difficult to assess the true impact of IUC on body weight due to a number of potential confounding factors [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>].</li></ul><h5>Decreased libido</h5><ul><li>The FSRH states that women should be advised that existing evidence fails to support a negative effect on libido associated with IUC use [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>]. </li><li>According to the FSRH, it is difficult to identify a causal relationship between the use of contraceptives and libido due to the impact of other potential influences, such as psychological and/or partner problems. Due to the limitations of observational research, however, an effect on libido with IUC use cannot be completely ruled out [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>].</li></ul><!-- end field 05ef1a22-c0fa-4523-aad1-7328f591e30f --><!-- end item b23e7f3d-d197-4f73-ae63-896ffcaab7ec -->","subChapters":[]}]},{"id":"2a2ef55b-5fe6-5bf3-8ca3-a8cb1fda7ca1","slug":"information-advice-for-the-woman","fullItemName":"Information and advice for the woman","depth":3,"htmlHeader":"<!-- begin field 22f3ece6-a7d2-40c5-900c-8a177280d0b0 --><h3>What information and advice should I give a woman considering starting a copper intrauterine device?</h3><!-- end field 22f3ece6-a7d2-40c5-900c-8a177280d0b0 -->","summary":null,"htmlStringContent":"<!-- begin item cfb1a313-422d-40ec-af9a-9f4af2ffc5a1 --><!-- begin field 52d7332c-cb02-48eb-afee-1f24d0f9cd42 --><ul><li><strong>Discuss </strong>the <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/background-information/mode-of-action/\">mode of action</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/background-information/efficacy/\">contraceptive efficacy</a>, <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/background-information/advantages-disadvantages/#copper-intrauterine-device\">advantages and disadvantages</a>, and possible <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/management/copper-intrauterine-device/#risks-adverse-effects\">risks and adverse effects</a> of the copper intrauterine device (Cu-IUD).</li><li><strong>Advise the woman:</strong><ul><li>On how to check for the Cu-IUD threads and the importance of doing this regularly (for example, after every menstrual period). </li><li>That the device can be removed at any time if she wishes to become pregnant and there is no delay in return to fertility.</li><li>That the Cu-IUD does not provide protection against sexually transmitted infections (STIs). Only a barrier method of contraception (such as a condom) can reduce the risk of STIs.</li></ul></li><li><strong>Advise the woman to seek medical advice if:</strong><br><ul><li>Menstrual abnormalities (such as unscheduled bleeding) persist beyond the initial 6 months of use.</li><li>She experiences possible features of pelvic inflammatory disease (pain or tenderness in the lower abdomen, fever, or abnormal or odorous vaginal discharge), especially within the first 3–4 weeks after insertion of the Cu-IUD. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pelvic-inflammatory-disease/\">Pelvic inflammatory disease</a> for management information.</li><li>She has mild lower abdominal pain and ‘lost threads’, especially with a history of pain at the time of insertion. These may indicate uterine perforation. </li><li>The device causes discomfort to her or her partner during sexual intercourse. (The threads can be cut shorter or flush within the cervical os if they cause irritation to a partner’s penis.)</li><li>She experiences any other <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/management/copper-intrauterine-device/#risks-adverse-effects\">adverse effect</a> of the Cu-IUD.</li></ul></li><li><strong>Provide information on:</strong><br><ul><li>The specific Cu-IUD that has been inserted and when it needs to be <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/background-information/types/\">removed and/or replaced</a>.</li><li>Other sources of useful information and advice regarding the Cu-IUD. For example, the Family Planning Association provides a useful <a href=\"http://www.fpa.org.uk/sites/default/files/intrauterine-device-iud-your-guide.pdf\" data-hyperlink-id=\"70d796c2-c331-46f1-8d08-a93100b62e78\">leaflet</a> with information for users of the Cu-IUD.</li></ul></li></ul><!-- end field 52d7332c-cb02-48eb-afee-1f24d0f9cd42 --><!-- end item cfb1a313-422d-40ec-af9a-9f4af2ffc5a1 -->","subChapters":[{"id":"cfcf3ac2-05f0-528d-ac0f-306c0df7baaf","slug":"basis-for-recommendation-a61","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field ae2e595c-1563-4069-85db-a7a700e59f15 --><h4>Basis for recommendation</h4><!-- end field ae2e595c-1563-4069-85db-a7a700e59f15 -->","summary":null,"htmlStringContent":"<!-- begin item a6147ac4-f50c-4559-86fd-a7a700e59d55 --><!-- begin field 35f4cd35-67d7-4fdd-b781-a7a700e59f15 --><p>These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guideline <em>Intrauterine contraception (April 2015, amended September 2019</em>) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>] and the Medicines and Healthcare products Regulatory Agency (MHRA) drug safety update <em>Intrauterine contraception: uterine perforation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">MHRA, 2015</a>].</p><!-- end field 35f4cd35-67d7-4fdd-b781-a7a700e59f15 --><!-- end item a6147ac4-f50c-4559-86fd-a7a700e59d55 -->","subChapters":[]}]},{"id":"72e36738-6b8a-5296-aa40-bcdcdce94592","slug":"managing-problems-associated-with-the-cu-iud","fullItemName":"Managing problems associated with the Cu-IUD","depth":3,"htmlHeader":"<!-- begin field 7d2e2c22-6b66-4c72-949b-2da0c841f839 --><h3>How should I manage problems associated with the copper intrauterine device?</h3><!-- end field 7d2e2c22-6b66-4c72-949b-2da0c841f839 -->","summary":null,"htmlStringContent":"<!-- begin item 16c9c9ec-a391-4fb7-b3fb-0c498c6b5590 --><!-- begin field 35eff68b-71ef-499e-9ea7-5cfdc283d5a4 --><!-- end field 35eff68b-71ef-499e-9ea7-5cfdc283d5a4 --><!-- end item 16c9c9ec-a391-4fb7-b3fb-0c498c6b5590 -->","subChapters":[{"id":"f1ed9e0c-e9bc-5ec3-a937-dcec7be67536","slug":"unscheduled-bleeding","fullItemName":"Unscheduled bleeding","depth":4,"htmlHeader":"<!-- begin field 0e52dc96-f17f-4d86-a51a-acce014fef69 --><h4>How should I manage unscheduled bleeding in a woman using a copper intrauterine device?</h4><!-- end field 0e52dc96-f17f-4d86-a51a-acce014fef69 -->","summary":null,"htmlStringContent":"<!-- begin item c1966a31-08f7-40e7-978b-a0ba31776e6e --><!-- begin field 0e7530a6-07c4-4fd0-8589-acce014fef69 --><p><strong>Irregular, prolonged, or frequent bleeding may occur in the 3–6 months following copper intrauterine device (Cu-IUD) insertion, but menstrual bleeding patterns tend to improve with time. </strong></p><ul><li><strong>For spotting and light bleeding:</strong><ul><li>Advise the woman that this is common during the first 3–6 months of Cu-IUD use, that it is not harmful, and that it usually decreases with time.</li><li>Consider prescribing a nonsteroidal anti-inflammatory drug (NSAID), such as mefenamic acid. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/menorrhagia/\">Menorrhagia</a> for more information.</li></ul></li><li><strong>For heavy and/or prolonged menstruation:</strong><br><ul><li><strong>Exclude and/or manage situations that could result in unscheduled bleeding, such as:</strong><ul><li>Sexually transmitted infections (STIs) — as a minimum, test for <em>Chlamydia trachomatis</em>. The risk of STIs is increased if the woman is under 25 years, has a new sexual partner, or has had more than one sexual partner in the last year. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia - uncomplicated genital</a> for more information.</li><li>Pregnancy — perform a pregnancy test.</li><li>Misplaced device — if this is suspected, arrange for ultrasonography to locate the device.</li><li>Gynaecological conditions, such as cervical and endometrial cancer — if suspected, refer the woman using a suspected cancer pathway referral (for an appointment within 2 weeks). For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gynaecological-cancers-recognition-referral/\">Gynaecological cancers - recognition and referral</a>.</li></ul></li><li style=\"box-sizing: inherit;\">Consider performing a speculum and pelvic examination:<ul><li>For persistent bleeding beyond the first 3–6 months of use. </li><li>For new symptoms or a change in bleeding after at least 3 months of use.</li><li>If the woman has not participated in the NHS Cervical Screening Programme regularly. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/cervical-cancer-hpv/\">Cervical cancer and HPV</a> and <a class=\"topic-reference external-reference\" href=\"/topics/cervical-screening/\">Cervical screening</a>.</li><li>If requested by the woman.</li><li>If there are other symptoms such as pelvic pain, dyspareunia, or postcoital bleeding. </li></ul></li><li style=\"box-sizing: inherit;\">Consider performing a transvaginal ultrasound scan and/or hysteroscopy: <ul style=\"box-sizing: inherit; font-feature-settings: 'kern', 'onum', 'liga'; margin-left: 1rem; max-width: 66ch; padding: 0px;\"><li style=\"box-sizing: inherit;\">If structural abnormalities (such as endometrial polyps) are suspected.</li></ul></li><li style=\"box-sizing: inherit;\"><strong>If no other underlying cause of irregular bleeding is suspected, and speculum and pelvic examinations are normal,</strong> the bleeding can be assumed to be caused by the Cu-IUD.<ul><li style=\"box-sizing: inherit;\">If heavy bleeding remains unacceptable or if there is evidence of anaemia, consider changing to another method of contraception. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a> for information on assessing women for the different methods of contraception.</li></ul></li><li style=\"box-sizing: inherit;\"><strong>Refer to gynaecology</strong> if the cause of the bleeding cannot be determined or treated in primary care.</li></ul></li></ul><!-- end field 0e7530a6-07c4-4fd0-8589-acce014fef69 --><!-- end item c1966a31-08f7-40e7-978b-a0ba31776e6e -->","subChapters":[]},{"id":"6aee35ba-662b-55e3-8c9c-d9a48e44de44","slug":"non-visible-threads","fullItemName":"Non-visible threads","depth":4,"htmlHeader":"<!-- begin field 8a690868-4613-4d7f-9920-acce014fef69 --><h4>How should I manage a woman who cannot feel the threads of her copper intrauterine device?</h4><!-- end field 8a690868-4613-4d7f-9920-acce014fef69 -->","summary":null,"htmlStringContent":"<!-- begin item 1f8873c5-a9fb-4fc4-a4c3-528c120a1e3b --><!-- begin field fd4e5c2c-c9db-4b85-8bd6-acce014fef69 --><p><strong>Intrauterine contraception (IUC) threads may not be visible in the vagina as a consequence of IUC expulsion, perforation of the wall of the uterus, or pregnancy, but often the cause is retraction of the threads into the cervical canal or uterus. </strong></p><ul><li><strong>If the woman cannot feel the threads of her copper intrauterine device (Cu-IUD):</strong><br><ul><li>Exclude pregnancy. </li><li>Perform a vaginal examination.<ul><li>If threads are not visible on speculum examination and uterine placement of the Cu-IUD cannot be confirmed clinically, refer the woman for an ultrasound scan to locate it. </li><li>Advise the woman to use a barrier method of contraception (such as condoms) or avoid unprotected sexual intercourse (UPSI) until it is confirmed whether or not the device is correctly in place. </li><li>Consider the need for emergency contraception if sexual intercourse occurred in the preceding 7 days. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-emergency/\">Contraception - emergency</a> for more information. </li></ul></li><li>If it is confirmed that the Cu-IUD is correctly located, it can be left in situ. <ul><li>If removal is required, a thread retriever or Spencer Wells forceps can be used if the appropriate training and experience are available in primary care.</li></ul></li><li>If ultrasonography cannot locate the device and pregnancy has been excluded, arrange for an abdominal and pelvic X-ray. <ul><li>If the device is extrauterine, or if partial perforation or embedment into the uterine wall is suspected, refer for surgical retrieval. </li><li>If the device is not located, this confirms expulsion. Offer reinsertion of a new Cu-IUD or an alternative method of contraception. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a> for information on assessing women for the different methods of contraception.</li></ul></li></ul></li></ul><!-- end field fd4e5c2c-c9db-4b85-8bd6-acce014fef69 --><!-- end item 1f8873c5-a9fb-4fc4-a4c3-528c120a1e3b -->","subChapters":[]},{"id":"66190f91-158e-5f9d-b245-8f7611a13688","slug":"pregnancy","fullItemName":"Pregnancy","depth":4,"htmlHeader":"<!-- begin field 06f78093-b656-4bcd-9619-acce014fef6a --><h4>How should I manage a woman who becomes pregnant whilst using a copper intrauterine device?</h4><!-- end field 06f78093-b656-4bcd-9619-acce014fef6a -->","summary":null,"htmlStringContent":"<!-- begin item 5def4667-6699-4047-86ea-42f212f0a51f --><!-- begin field c9adf091-cc14-42ed-88de-acce014fef6a --><ul><li><strong>If a woman is found to be pregnant whilst using the copper intrauterine device (Cu-IUD), </strong>seek immediate advice from a gynaecologist.</li></ul><!-- end field c9adf091-cc14-42ed-88de-acce014fef6a --><!-- end item 5def4667-6699-4047-86ea-42f212f0a51f -->","subChapters":[]},{"id":"107896fc-e610-5473-85b1-55a35bf3cd0b","slug":"presence-of-actinomyces-like-organisms-on-smears","fullItemName":"Presence of actinomyces-like organisms on smears","depth":4,"htmlHeader":"<!-- begin field 6ee34ca7-5359-4555-a3e3-acce014fef6a --><h4>How should I manage a woman who has actinomyces-like organisms on a cervical smear and is using a copper intrauterine device?</h4><!-- end field 6ee34ca7-5359-4555-a3e3-acce014fef6a -->","summary":null,"htmlStringContent":"<!-- begin item 270bfa06-6c89-4d51-8731-f1ea525d9930 --><!-- begin field 8ec1838c-7dae-4ae0-a7e9-acce014fef6a --><p><strong><em>Actinomyces israelii</em> is a commensal of the female genital tract. Actinomyces-like organisms (ALOs) have been identified in women with and without intrauterine contraception (IUC), but the role of ALOs in infection in women using IUC is unclear.</strong></p><ul><li><strong>If the woman has ALOs and is asymptomatic:</strong> <ul><li>There is no need to remove a copper intrauterine device (Cu-IUD) in situ.</li><li>For women who require a replacement Cu-IUD, there is some evidence to suggest that immediate reinsertion or a short delay of 3–5 days is safe.</li></ul></li><li><strong>If the woman has ALO and pelvic pain:</strong><ul><li>Consider removing the Cu-IUD.</li><li>Assess the woman for features of pelvic inflammatory disease. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pelvic-inflammatory-disease/\">Pelvic inflammatory disease</a> for more information.</li><li style=\"box-sizing: inherit;\">Assess for other more common causes of pain, including sexually transmitted infections (STIs).</li></ul></li></ul><!-- end field 8ec1838c-7dae-4ae0-a7e9-acce014fef6a --><!-- end item 270bfa06-6c89-4d51-8731-f1ea525d9930 -->","subChapters":[]},{"id":"e55789d6-37e0-59d3-a789-ca1fb14883e0","slug":"suspected-pelvic-inflammatory-disease","fullItemName":"Suspected pelvic inflammatory disease","depth":4,"htmlHeader":"<!-- begin field 790439b8-d3ab-4757-96e7-acce014fef6a --><h4>How should I manage pelvic inflammatory disease in a woman using a copper intrauterine device?</h4><!-- end field 790439b8-d3ab-4757-96e7-acce014fef6a -->","summary":null,"htmlStringContent":"<!-- begin item ac99c1e6-9786-48c9-bc88-2f60aff40320 --><!-- begin field 1f6d9032-9f88-4a36-9577-acce014fef6a --><p><strong>There is a low risk of pelvic inflammatory disease (PID), which is strongly related to the insertion procedure and background risk of sexually transmitted infections (STIs). The risk of pelvic infection is greatest in the first few weeks following insertion of intrauterine contraception.</strong></p><ul><li><strong>If PID is diagnosed in a woman using the copper intrauterine device (Cu-IUD):</strong><ul><li>There is no need for routine removal of the Cu-IUD. Test for the causative organism, and start appropriate antibiotic treatment. </li><li>Consider removing the Cu-IUD if the woman wishes or if symptoms have not resolved within 72 hours. <ul><li>If the device is removed and the woman has had sexual intercourse within the last 7 days, consider offering emergency hormonal contraception. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-emergency/\">Contraception - emergency</a> for prescribing information.</li></ul></li><li>Follow up women 72 hours after treatment and 2–4 weeks after treatment if required. </li><li>See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/pelvic-inflammatory-disease/\">Pelvic inflammatory disease</a> for more information on managing PID.</li></ul></li></ul><!-- end field 1f6d9032-9f88-4a36-9577-acce014fef6a --><!-- end item ac99c1e6-9786-48c9-bc88-2f60aff40320 -->","subChapters":[]},{"id":"accb637b-09af-5654-98c8-fddd39c5eb99","slug":"suspected-uterine-perforation","fullItemName":"Suspected uterine perforation","depth":4,"htmlHeader":"<!-- begin field 5bbf95fd-8b2e-44f4-81f1-acce014fef6a --><h4>How should I manage suspected uterine perforation in a woman using a copper intrauterine device?</h4><!-- end field 5bbf95fd-8b2e-44f4-81f1-acce014fef6a -->","summary":null,"htmlStringContent":"<!-- begin item b7203d32-5829-4c30-a538-e6e24d2f368c --><!-- begin field 8487a502-570d-45f9-aec9-acce014fef6a --><p><strong>Perforation of the wall of the uterus is rare and is dependent on the skills of the clinician. There is an increased relative risk of perforation at the time of insertion of intrauterine contraception (IUC) in the postpartum period (within 36 weeks after giving birth) and during breastfeeding; however, the absolute risk of perforation remains low.</strong></p><ul><li><strong>If the perforation is identified at the time of insertion:</strong><ul><li>Stop the procedure.</li><li>Remove the device.</li><li>Monitor vital signs (blood pressure and pulse rate) and level of discomfort until the woman is stable.</li></ul></li><li><strong>If there is any possibility of perforation at the time of insertion or later:</strong><ul><li>Arrange an ultrasound scan and, if indicated, a plain abdominal and pelvic X-ray as soon as possible in order to locate the device.</li><li>Advise the woman to avoid sexual intercourse or use a barrier method of contraception (such as condoms) in the interim.</li></ul></li><li><strong>Note that</strong> mild lower abdominal pain, ‘lost threads’, and a history of pain at the time of insertion may indicate uterine perforation. The threads may remain in the vagina and may break off at attempted removal if an IUC has become embedded in the uterine wall or has perforated the cervix.</li></ul><!-- end field 8487a502-570d-45f9-aec9-acce014fef6a --><!-- end item b7203d32-5829-4c30-a538-e6e24d2f368c -->","subChapters":[]},{"id":"ba4a7108-9406-5379-8e4d-971f9b78f389","slug":"basis-for-recommendation-1c7","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 93ed32b5-eae1-4345-999d-198c91ae8708 --><h4>Basis for recommendation</h4><!-- end field 93ed32b5-eae1-4345-999d-198c91ae8708 -->","summary":null,"htmlStringContent":"<!-- begin item 1c76785f-21b7-4674-91ea-f2e5649b6f19 --><!-- begin field a7507791-dea9-4f60-8541-7eee309cf6a6 --><p>These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guideline <em>Intrauterine contraception (April 2015, amended September 2019)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>].</p><h5>Pregnancy</h5><ul><li>The recommendation to seek immediate advice from a gynaecologist if a woman is found to be pregnant whilst using the copper intrauterine device (Cu-IUD) is based on what CKS considers to be good clinical practice.</li></ul><!-- end field a7507791-dea9-4f60-8541-7eee309cf6a6 --><!-- end item 1c76785f-21b7-4674-91ea-f2e5649b6f19 -->","subChapters":[]}]},{"id":"bce99bcb-477a-5415-90f5-0949c80b824c","slug":"follow-up","fullItemName":"Follow up","depth":3,"htmlHeader":"<!-- begin field 96a5a3bb-bea8-48c9-986e-a5ac97f3fb85 --><h3>What follow up should I consider for a woman using a copper intrauterine device?</h3><!-- end field 96a5a3bb-bea8-48c9-986e-a5ac97f3fb85 -->","summary":null,"htmlStringContent":"<!-- begin item 769ddc6a-f3cf-4aba-8110-d8d7f42e2322 --><!-- begin field 27ea6198-4da4-44a0-b95d-81293d21761b --><ul><li><strong>Consider arranging follow up after the first menses following insertion of <strong>the copper intrauterine device (Cu-IUD)</strong> or 3–6 weeks later, </strong>to exclude infection, perforation, or expulsion. However, it is not essential. </li><li><strong>Advise the woman to return any time if she:</strong><br><ul><li>Has symptoms of pelvic pain, abnormal bleeding, infection, perforation, or expulsion.</li><li>Is unable to feel the threads of her Cu-IUD.</li><li>Thinks that she might be pregnant.</li><li>Wants to change her method of contraception or her Cu-IUD is due to be changed.</li></ul></li></ul><!-- end field 27ea6198-4da4-44a0-b95d-81293d21761b --><!-- end item 769ddc6a-f3cf-4aba-8110-d8d7f42e2322 -->","subChapters":[{"id":"3a4b7219-dc54-5b60-a2ba-1926d7c10401","slug":"basis-for-recommendation-5ff","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field df15ea30-2741-4875-bd08-f581aee19d3e --><h4>Basis for recommendation</h4><!-- end field df15ea30-2741-4875-bd08-f581aee19d3e -->","summary":null,"htmlStringContent":"<!-- begin item 5ff426bc-76a4-4d58-b9f8-6ba57c0f5d36 --><!-- begin field 40fa33e8-103f-4b1c-a10e-9f48f4a9c900 --><p>These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guideline <em>Intrauterine contraception (April 2015, amended September 2019)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>].</p><!-- end field 40fa33e8-103f-4b1c-a10e-9f48f4a9c900 --><!-- end item 5ff426bc-76a4-4d58-b9f8-6ba57c0f5d36 -->","subChapters":[]}]},{"id":"27a89d93-159d-53f7-9a59-b76b2cb06b38","slug":"timing-of-removal-replacement","fullItemName":"Timing of removal/replacement","depth":3,"htmlHeader":"<!-- begin field ed387414-10a1-4f27-8680-acce016c79aa --><h3>When can the copper intrauterine device be safely removed or replaced?</h3><!-- end field ed387414-10a1-4f27-8680-acce016c79aa -->","summary":null,"htmlStringContent":"<!-- begin item 7c4b50b2-8565-41aa-bae0-b909fa47c912 --><!-- begin field 8362c65e-b602-4950-8727-acce016c79aa --><ul><li><strong>For women who wish to become pregnant:</strong><ul><li>Remove the copper intrauterine device (Cu-IUD) at any time in the menstrual cycle.</li><li>Offer pre-pregnancy advice regarding lifestyle, diet, folic acid, rubella immunity, and vitamin D. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/antenatal-care-uncomplicated-pregnancy/\">Antenatal care - uncomplicated pregnancy</a> for more information.</li></ul></li><li><strong>For women who do not wish to become pregnant:</strong><br><ul><li><strong>If removal is within the <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/background-information/types/\">licensed duration of use</a> and an alternative method is chosen, </strong>see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-assessment/\">Contraception - assessment</a> for information on assessing women for the different methods of contraception.</li><li><strong>If replacement </strong><strong><strong>is within the <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/background-information/types/\">licensed duration of use</a></strong>, </strong>see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/management/copper-intrauterine-device/#switching-to-a-cu-iud\">Switching to the copper intrauterine device</a> for information on replacing an existing Cu-IUD with a new Cu-IUD.</li></ul></li><li><strong>If removal/replacement is</strong><strong><strong> outside the <a class=\"topic-reference internal-reference\" href=\"/topics/contraception-ius-iud/background-information/types/\">licensed duration of use</a></strong> and/or the woman is approaching the menopause:</strong><ul><li>A Cu-IUD inserted at or after the age of 40 years can be retained until 1 year after the last menstrual period if this occurs when the woman is over the age of 50 years (or 2 years after the last menstrual period if she is younger than 50 years of age), after which the device should be removed. </li><li>All other women who wish replacement of a Cu-IUD outside the licensed duration of use should have pregnancy reliably excluded prior to the replacement, or fit the criteria for an emergency IUD. </li><li><strong>Once a woman reaches 55 years of age, contraception can be stopped even if she is still experiencing menstrual bleeding.</strong><ul><li>Some women may wish to continue using a Cu-IUD beyond this age for reasons relating to perceived non-contraceptive benefits.</li><li>Advise that the device should not be left in situ indefinitely after it is no longer required as it could become a focus of infection. </li></ul></li></ul></li><li><strong>If a Cu-IUD is inadvertently inserted after the expiry date stated on the packaging:</strong><br><ul><li>Advise the woman that if the device has only recently expired, it is unlikely to affect contraceptive efficacy.</li><li>The risk of infection from loss of microbiological sterility is likely to be lower than the risk of infection from replacement of the device. Consequently, the device does not necessarily need to be removed unless requested by the woman.</li><li>Manage the error according to local clinical governance policies.</li></ul></li></ul><!-- end field 8362c65e-b602-4950-8727-acce016c79aa --><!-- end item 7c4b50b2-8565-41aa-bae0-b909fa47c912 -->","subChapters":[{"id":"195154d7-717e-59ea-9b73-29781eec98e8","slug":"basis-for-recommendation-849","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 89227d80-ab98-42ee-b3f2-acce016c79aa --><h4>Basis for recommendation</h4><!-- end field 89227d80-ab98-42ee-b3f2-acce016c79aa -->","summary":null,"htmlStringContent":"<!-- begin item 84947745-378f-4b57-8db7-b8fe19339ba7 --><!-- begin field a56981b5-fb2c-4cc9-91ab-acce016c79aa --><p>These recommendations are largely based on the Faculty of Sexual and Reproductive Healthcare (FSRH) guidelines <em>Intrauterine contraception (April 2015, amended September 2019)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019a</a>] and <em>Contraception for women aged over 40 years</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019b</a>].</p><h5>Women aged over 55 years</h5><ul><li>The FSRH states that in general, all women can cease contraception at age 55 years as spontaneous conception after this age is exceptionally rare even in women still experiencing menstrual bleeding [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019b</a>].</li><li>If a woman aged 55 years or over does not wish to stop a particular method, consideration can be given to continuation providing the benefits and risks have been assessed and discussed with the woman. The device should not be left in situ indefinitely after it is no longer required as it could become a focus of infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/contraception-ius-iud/references/\">FSRH, 2019b</a>].</li></ul><!-- end field a56981b5-fb2c-4cc9-91ab-acce016c79aa --><!-- end item 84947745-378f-4b57-8db7-b8fe19339ba7 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}